Literature DB >> 15576039

A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains.

Meytal Landau1, Sarel J Fleishman, Nir Ben-Tal.   

Abstract

Tyrosine kinase receptors of the EGFR family play a significant role in vital cellular processes and in various cancers. EGFR members are unique among kinases, as the regulatory elements of their kinase domains are constitutively ready for catalysis. Nevertheless, the receptors are not constantly active. This apparent paradox has prompted us to seek mechanisms of regulation in EGFR's cytoplasmic domain that do not involve conformational changes of the kinase domain. Our computational analyses, based on the three-dimensional structure of EGFR's kinase domain suggest that direct contact between the kinase and a segment from the C-terminal regulatory domains inhibits enzymatic activity. EGFR activation would then involve temporal dissociation of this stable complex, for example, via ligand-induced contact formation between the extracellular domains, leading to the reorientation of the transmembrane and intracellular domains. The model provides an explanation at the molecular level for the effects of several cancer-causing EGFR mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576039     DOI: 10.1016/j.str.2004.10.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  28 in total

1.  Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Authors:  Wanping Xu; Xitong Yuan; Kristin Beebe; Zhexin Xiang; Len Neckers
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

2.  EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism.

Authors:  G Pines; P H Huang; Y Zwang; F M White; Y Yarden
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

Review 3.  Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy.

Authors:  Gur Pines; Wolfgang J Köstler; Yosef Yarden
Journal:  FEBS Lett       Date:  2010-04-11       Impact factor: 4.124

4.  Kinase-mediated quasi-dimers of EGFR.

Authors:  Erez M Bublil; Gur Pines; Gargi Patel; Gilbert Fruhwirth; Tony Ng; Yosef Yarden
Journal:  FASEB J       Date:  2010-08-03       Impact factor: 5.191

5.  An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.

Authors:  Stuart McLaughlin; Steven O Smith; Michael J Hayman; Diana Murray
Journal:  J Gen Physiol       Date:  2005-06-13       Impact factor: 4.086

6.  A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.

Authors:  Vincent W Keng; Augusto Villanueva; Derek Y Chiang; Adam J Dupuy; Barbara J Ryan; Ilze Matise; Kevin A T Silverstein; Aaron Sarver; Timothy K Starr; Keiko Akagi; Lino Tessarollo; Lara S Collier; Scott Powers; Scott W Lowe; Nancy A Jenkins; Neal G Copeland; Josep M Llovet; David A Largaespada
Journal:  Nat Biotechnol       Date:  2009-02-22       Impact factor: 54.908

7.  Dynamic transition states of ErbB1 phosphorylation predicted by spatial stochastic modeling.

Authors:  Meghan McCabe Pryor; Shalini T Low-Nam; Adám M Halász; Diane S Lidke; Bridget S Wilson; Jeremy S Edwards
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

Review 8.  The ErbB kinase domain: structural perspectives into kinase activation and inhibition.

Authors:  Ron Bose; Xuewu Zhang
Journal:  Exp Cell Res       Date:  2008-08-15       Impact factor: 3.905

9.  A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer.

Authors:  Hidefumi Sasaki; Katsuhiro Okuda; Minoru Takada; Masaaki Kawahara; Naoto Kitahara; Akihide Matsumura; Keiji Iuchi; Tomoya Kawaguchi; Akihiko Kubo; Katsuhiko Endo; Osamu Kawano; Haruhiro Yukiue; Motoki Yano; Yoshitaka Fujii
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

10.  Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain.

Authors:  B H Ozer; G J Wiepz; P J Bertics
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.